Printer Friendly

11th Annual Conference on Vaccine Research.

CDC and 11 other national and international agencies and organizations will collaborate with the National Foundation for Infectious Diseases in sponsoring the 11th Annual Conference on Vaccine Research: Basic Science, Product Development, and Clinical and Field Studies, to be held May 5-7, 2008, at the Marriott Waterfront Hotel, Baltimore, Maryland. The conference is the largest scientific forum devoted exclusively to the research and development of vaccines and related technologies for prevention and treatment of disease through immunization, bringing together human and veterinary vaccinology researchers. Twenty-two invited speakers will appear at five special symposia on innate immunity, cutaneous vaccination, adjuvants, universal influenza vaccination, and recently licensed vaccines. Six oral sessions and posters will include presentations selected through peer review from submitted abstracts. Eligible abstracts will be considered for the Maurice R. Hilleman Early-Stage Career Investigator Award, which provides $10,000 for research expenses and a travel stipend and registration for the 2009 conference.

Deadline for submission of abstracts is February 15, 2008. Information about the preliminary program, abstract submission, registration, hotel accommodation, and exhibition space is available at vaccine08, and by e-mail (, fax (301-907-0878), telephone (301-656-0003, ext. 19), and mail (NFID, Suite 750, 4733 Bethesda Avenue, Bethesda, MD 20814-5278).

COPYRIGHT 2008 U.S. Government Printing Office
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Notice to Readers
Publication:Morbidity and Mortality Weekly Report
Article Type:Brief article
Geographic Code:1U5MD
Date:Jan 4, 2008
Previous Article:Requirements for use of a new International Certificate of Vaccination or Prophylaxis for yellow fever vaccine.
Next Article:Table 1. Provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year)--United States, week ending...

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters